Gene Editing Will Change Medicine—and Maybe Health Investing Too

It usually takes time for scientific discoveries in the lab to make their way to the…

New Treatment for Bladder Cancer Offers This Biotech a Second Chance

UroGen hopes to have success with a new treatment after its first drug was a commercial…

Ozempic Settles the Obesity Debate: It’s Biology Over Willpower

Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight.

Doctors Desperately Need Drugs to Kill Deadly Fungi. It’s an Uphill Fight.

Research shows that antifungals are being weakened before the fungicides come up for approval.

The $76 Billion Diet Industry Asks: What to Do About Ozempic?

The weight-loss business, which long pioneered calorie counting and willpower, is grappling with the growing popularity…

The $76 Billion Diet Industry Asks: What to Do About Ozempic?

The weight-loss business, which long pioneered calorie counting and willpower, is grappling with the growing popularity…

A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.

Pharmaceutical companies may try to cap the price hike in future.

Opinion | The FDA and an ALS Treatment

Few diseases are as cruelly debilitating as amyotrophic lateral sclerosis (ALS). But a Food and Drug…

FDA Approves Bluebird’s $2.8 Million Gene Therapy for Rare Blood Disease

The Food and Drug Administration approved a gene therapy from Bluebird Bio Inc. that represents a…

opinion | Biden may block the launch of his cancer moonshot

In his last year as Vice President, Joe Biden Launched “Cancer Moonshot” to expedite the treatment…